Shares of US clinical-stage company Eledon Pharmaceuticals shot up 9.9% to close at $3.44 yesterday, after it announced ...

Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m² post-transplant Preliminary iBox data, a key biomarker of kidney function ...

Uppsala University Hospital-led investigators report that gene-edited donor islet cells survived 12 weeks inside a man with ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced positive results ...

Praxis Precision Medicines (PRAX) stock gains on mid-stage trial data for its anti-seizure therapy vormatrigine. Read more ...

SynOx Therapeutics has completed subject enrolment in its multi-centre Phase III TANGENT trial of the humanised IgG1 ...

Tryptamine Therapeutics is edging closer to first patient dosing in its world-first clinical trial for binge eating disorder ...

Traversa communicated that the company intends "to initiate a Phase III study for NDV-01 in the first half of 2026" and to start a "proof-of-concept study in PWS in the first half of 2026" for ...

Akeso initiates a pivotal trial for cadonilimab and lenvatinib, targeting advanced liver cancer resistant to PD-1 therapy, ...

Anbogen Therapeutics gains FDA approval for ABT-301, initiating a pivotal trial for metastatic colorectal cancer, targeting ...

Atavistik Bio has dosed the first subject in its Phase I clinical trial of ATV-1601, designed to treat adults with solid tumours.

Genmab (Otc) (($GMAB)) announced an update on their ongoing clinical study. Study Overview: Genmab is conducting a clinical trial titled ...